NCT03253822

Brief Summary

The aim of the trial is to test the effect of a web-based decision aid (DA) on colorectal cancer (CRC) knowledge, decisional conflict, participation rate, and informed choice (evaluated based on knowledge, attitudes and actual participation). The study includes three study arms. Citizens to be recruited are identified from the Danish Civil Registration System based on residence (Central Denmark Region), age (50-74 years old), and month of birth. A random sample of 15,000 citizens born in December (invited for CRC screening through October/November/December 2017) (study arm 1+2) and 5,000 citizens born in October (invited for CRC screening in January/February 2017) (study arm 3) is identified. Citizens in study arm 1+2 will receive a baseline questionnaire assessing knowledge, attitudes, worry, and health literacy. Non respondents will receive one reminder after two weeks and after four weeks non-respondents will receive a phone call, offering them to fill out the questionnaire via the phone. Baseline questionnaire respondents are included in the study, and will be randomized into two study arms (intervention group and control group). Citizens in the intervention group will be identified in the screening IT system. Date of screening invitation and screening reminder (citizens who do not return a stool sample within 45 days of the screening invitation) is retrieved. Citizens receiving a screening reminder will receive a link for the DA. Follow-up questionnaire will be sent to all included citizens in study-arm 1+2 three months after the last screening invitation has been sent out. Citizens have six weeks to respond to the questionnaire. Study arm 3 is a historic cohort. The citizens receive only one questionnaire at the same time as the baseline questionnaires are sent out to the intervention and control groups. The citizens are included if they respond to the questionnaire within six weeks. Questionnaire reminders are sent out at two and four weeks. Data on screening invitation date, screening reminder date, returning a stool sample and result will be retrieved from the screening IT system for all included citizens (Study arm 1-3). Lastly, data from Statistics Denmark (on socio-demographic and socio-economic factors) will be included.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15,030

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 13, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

August 15, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 18, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2018

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 23, 2018

Completed
Last Updated

October 2, 2018

Status Verified

October 1, 2018

Enrollment Period

8 months

First QC Date

July 13, 2017

Last Update Submit

October 1, 2018

Conditions

Keywords

Colorectal NeoplasmsDecision Support TechniquesEarly Detection of CancerEducational StatusDecision MakingKnowledge, Attitudes, Practice

Outcome Measures

Primary Outcomes (3)

  • CRC and CRC screening knowledge

    Assessed using questionnaire. Six items yielding a scale score between 0 and 100 %. Continous variable.

    Assessed before screening invitation (study arm 1+2) and at least three months after screening invitation (study arm 1+2+3)

  • CRC screening attitude

    Assessed using questionnaire. Four items. Scores between 7 and 28. Continuous variable.

    Assessed before screening invitation (study arm 1+2) and at least three months after screening invitation (study arm 1+2+3)

  • CRC screening participation

    Binary outcome (yes/no), retrieved from screening IT system.

    Obtained at least three months after screening invitation.

Secondary Outcomes (8)

  • CRC worry

    Assessed before screening invitation (study arm 1+2) and at least three months after screening invitation (study arm 1+2+3)

  • Decisional conflict

    Assessed at least three months after invitation (study arm 1+2+3)

  • Health literacy

    Assessed before screening invitation (study arm 1+2) or at least three months after screening invitation (study arm 3)

  • Educational level

    Up to 12 months before screening invitation

  • Family income

    Up to 12 months before screening invitation

  • +3 more secondary outcomes

Study Arms (3)

Intervention group

EXPERIMENTAL

This group receives a baseline questionnaire before their screening invitation. Respondents are included, and those receiving a screening reminder receive the decision aid. At least three months after their screening invitation the included citizens (baseline questionnaire respondents) will receive a follow-up questionnaire.

Other: Decision aid

Control group

NO INTERVENTION

This group receives a baseline questionnaire before their screening invitation. Respondents are included. At least three months after their screening invitation, baseline questionnaire respondents will receive a follow-up questionnaire.

Historic cohort

NO INTERVENTION

A group of people already invited for colorectal cancer screening. This group receives a questionnaire at least three months after their screening invitation. Respondents are included in the study.

Interventions

The DA is an online tool. The web-based design opens up possibilities to feature more advanced functions, e.g. questions for the participant during the process, and a summary of answers at the end. The DA is tailored to lower educational attainment citizens, and is designed to embrace different information needs in the target population, ranging from a desire to receive a clear recommendation and a minimum of information to the desire to receive full information and make a personalized choice.

Also known as: DA
Intervention group

Eligibility Criteria

Age50 Years - 74 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Random sample of citizens 50-74 years of age.
  • Resident in the Central Denmark Region at time of data extraction (August 2017)
  • Month of birth: December or October

You may not qualify if:

  • Non-respondents to baseline questionnaire (study arm 1+2) or questionnaire (study arm 3)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Public Health Programmes, Randers Regional Hospital

Randers, DK-8930, Denmark

Location

MeSH Terms

Conditions

BehaviorColorectal Neoplasms

Interventions

Decision Support Techniques

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Pernille Gabel, MD PhD Fel.

    Department of Public Health Programmes, Randers Regional Hospital, Central Denmark Region, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Since baseline questionnaire is filled out before randomizasion, and citizens will know if they receive the DA or not, participants will not be masked. No care providers are involved in the screening program in the phases we study (invitation, reminder, and stool sample), hence no masking in this groups. The outcomes are assessed via questionnaire data or from registries (Statistics Denmark and the screening IT system), and no masking is necessary in neither investigators nor outcomes assessors.
Purpose
SCREENING
Intervention Model
PARALLEL
Model Details: The LEAD trial is conducted as a two arm, randomised controlled trial nested into a population-based, organized CRC screening programme conducted in the Central Denmark Region. Citizens who are scheduled to be invited for CRC screening within the study period will be randomly allocated into one two study arms. Further, a historic study arm will be included, in order to be able to assess the effect of receiving the baseline questionnaire: 1. To receive the DA along with the screening reminder and to receive both baseline and follow-up questionnaires (intervention group) 2. To receive both baseline and follow-up questionnaires (control group) 3. To receive a questionnaire comprisng scales from both baseline and follow-up questionnaires (historic cohort) Regardless of study arm, all citizens receive standard CRC screening information material according to the CRC screening program procedures.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D. PhD Fellow

Study Record Dates

First Submitted

July 13, 2017

First Posted

August 18, 2017

Study Start

August 15, 2017

Primary Completion

April 3, 2018

Study Completion

April 23, 2018

Last Updated

October 2, 2018

Record last verified: 2018-10

Data Sharing

IPD Sharing
Will not share

No individual patient data are to be shared with other researchers.

Locations